CommentaryPublished 8 Mar 2018
Clinical Approach to Statin-Induced Adverse Muscle Events: Challenges and Solutions
Abstract
Statin-associated adverse muscle events play an important role in statin non adherence and discontinuation. Aspects of this clinical challenge including a lack of a uniform definition of statin-induced myalgia, the “nocebo” effect and its’ role in statin-induced adverse muscle events, pre-existing medical and lifestyle factors that can affect statin therapy, and restarting statin use in patients after prior discontinuation of statin therapy due to adverse muscle effects. This paper applies the recommendations of the National Lipid Association’s Statin Muscle Safety Task Force along with other studies to propose solutions for these challenges that statin-induced adverse muscle events present. Future large randomized controlled trials will be necessary for validation of these clinical interventions.
Subjects
Public Health & EpidemiologyFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Preventive Medicine
- SubjectPublic Health & Epidemiology
- BylineArticles whose byline prints “Kwame Nuako”
